United Therapeutics Corporation Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral
April 29, 2016 8:26 AM EDTLadenburg Thalmann downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Neutral.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $104.84 yesterday.
... MoreUnited Therapeutics (UTHR) Misses Q1 EPS by 19c
April 28, 2016 9:25 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.02, $0.19 worse than the analyst estimate of $3.21. Revenue for the quarter came in at $369 million versus the consensus estimate of $397.42 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
... More